Shortcomings in the evaluation of biomarkers in ovarian cancer: a systematic review

Background: Shortcomings in study design have been hinted at as one of the possible causes of failures in the translation of discovered biomarkers into the care of ovarian cancer patients, but systematic assessments of biomarker studies are scarce. We aimed to document study design features of recently reported evaluations of biomarkers in ovarian cancer. Methods: We performed a systematic search in PubMed (MEDLINE) for reports of studies evaluating the clinical performance of putative biomarkers in ovarian cancer. We extracted data on study designs and characteristics. Results: Our search resulted in 1026 studies; 329 (32%) were found eligible after screening, of which we evaluated the first 200. Of these, 93 (47%) were single center studies. Few studies reported eligibility criteria (17%), sampling methods (10%) or a sample size justification or power calculation (3%). Studies often used disjoint groups of patients, sometimes with extreme phenotypic contrasts; 46 studies included healthy controls (23%), but only five (3%) had exclusively included advanced stage cases. Conclusions: Our findings confirm the presence of suboptimal features in clinical evaluations of ovarian cancer biomarkers. This may lead to premature claims about the clinical value of these markers or, alternatively, the risk of discarding potential biomarkers that are urgently needed.

Angaben zum Objekt

• Standort: Deutsche Nationalbibliothek Frankfurt am Main
• Umfang: Online-Ressource
• Sprache: Englisch

Verweise und Beziehungen

• Erschienen in: Shortcomings in the evaluation of biomarkers in ovarian cancer: a systematic review ; volume:58 ; number:1 ; year:2019 ; pages:3-10 ; extent:8 ; Clinical chemistry and laboratory medicine ; 58, Heft 1 (2019), 3-10 (gesamt 8)

Beteiligte, Orts- und Zeitangaben

• Urheber: Olsen, Maria ; Ghannad, Mona ; Lok, Christianne ; Bossuyt, Patrick M.

Weitere Informationen

• DOI: 10.1515/cclm-2019-0038
• URN: urn:nbn:de:101:1-2022061014290893914524
• Rechteinformation: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
• Letzte Aktualisierung: 15.08.2025, 07:36 MESZ